XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit
Income tax benefit consists of the following:
Year Ended December 31,Six-month Transition Period Ended December 31,Years Ended June 30,
(in millions)2021202020202019
Current:
Federal$(1.9)$(75.8)$26.6 $(24.2)
State3.6 (0.6)4.9 (0.1)
Foreign0.1 0.2 0.5 0.2 
Total current1.8 (76.2)32.0 (24.1)
Deferred:
Federal(33.7)39.1 (51.5)17.8 
State5.1 (3.4)(4.1)1.7 
Foreign0.1 (0.5)(3.6)0.4 
Change in valuation allowance(3.2)— 3.5 (0.2)
Total deferred(31.7)35.2 (55.7)19.7 
Total income tax benefit$(29.9)$(41.0)$(23.7)$(4.4)
Schedule of Income (Loss) Before Income Taxes
Income (loss) before income taxes consists of the following:
Year Ended December 31,Six-month Transition Period Ended December 31,Years Ended June 30,
(in millions)2021202020202019
United States$(53.8)$(101.8)$(240.9)$(0.6)
Foreign(3.3)7.7 17.6 0.6 
Total$(57.1)$(94.1)$(223.3)$— 
Schedule of Differences Between Statutory Federal Income Tax Rate and Income Taxes Reported
The differences between income taxes at the statutory federal income tax rate and income taxes reported in the Consolidated Statements of Operations were as follows:
Year Ended December 31,Six-month Transition Period Ended December 31,Years Ended June 30,
(in millions)2021202020202019
Federal income tax expense at the statutory rate$(12.0)21.0 %$(19.8)21.0 %$(46.9)21.0 %$— 21.0 %
State income taxes, net of federal benefit(1.8)3.2 %(1.2)1.3 %4.0 (1.8)%2.0 6,422.1 %
Research and development credits2.5 (4.4)%(1.3)1.4 %(2.8)1.3 %(3.7)(11,880.9)%
Uncertain tax positions(3.0)5.3 %0.6 (0.7)%1.5 (0.7)%(4.2)(13,486.4)%
Incentive stock option and employee stock purchase plan expense0.7 (1.2)%2.5 (2.7)%(0.2)0.1 %(3.1)(9,954.3)%
Foreign rate differential0.5 (0.9)%(2.1)2.2 %0.7 (0.3)%0.8 2,568.8 %
Change in valuation allowance(3.2)5.6 %(0.3)0.3 %3.5 (1.7)%(0.2)(642.2)%
CARES Act2.7 (4.7)%(20.7)22.0 %— — %— — %
Non-deductible meals and entertainment0.1 (0.2)%0.5 (0.5)%1.8 (0.8)%1.3 4,174.4 %
Non-deductible officer compensation3.3 (5.8)%0.1 (0.1)%1.6 (0.7)%0.6 1,926.6 %
Asset impairment— — %— — %12.6 (5.6)%— — %
Non-deductible legal settlement2.5 (4.5)%— — %— — %1.9 6,101.0 %
Acquisitions, Dispositions, and Contingent Consideration(23.0)40.3 %0.7 (0.7)%(0.3)0.1 %0.8 2,568.8 %
Method changes or tax elections— — %— — %— — %(0.9)(2,890.0)%
Other, net0.8 (1.4)%— — %0.8 (0.3)%0.3 963.4 %
Total income tax benefit$(29.9)52.3 %$(41.0)43.5 %$(23.7)10.6 %$(4.4)-14,107.7 %
Schedule of Components of Deferred Tax Assets and Liabilities
The significant components of the Company’s deferred tax assets and liabilities were comprised of the following:
December 31,
(in millions)20212020
Deferred tax assets:
Net operating loss carryforwards$67.2 $72.2 
Deferred revenue1.2 7.2 
Stock compensation expense4.5 11.5 
Research and development credits17.3 24.9 
Lease right-of-use asset22.4 15.2 
Accrued expenses and liabilities14.2 7.6 
Other, net4.5 6.4 
Total gross deferred tax assets131.3 145.0 
Less valuation allowance(38.5)(42.0)
Total deferred tax assets92.8 103.0 
Deferred tax liabilities:
Intangible assets104.9 144.0 
Lease liability20.2 14.6 
Property, plant and equipment3.5 15.7 
Total deferred tax liabilities128.6 174.3 
Net deferred tax liability$(35.8)$(71.3)
Schedule of Net Operating Loss and Research Credit Carryforwards (Tax Effected)
At December 31, 2021, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):
CarryforwardsAmountSubject to
sections 382, 383
Expires
beginning in year
Through
Federal net operating loss$31.2 Yes20362037
Federal capital loss13.5 No20262026
Utah net operating loss2.4 No2022Indefinite
California net operating loss3.9 Yes20272042
Other state net operating loss7.4 Yes20272041
Foreign net operating losses (various jurisdictions)8.8 NoVariousVarious
Federal research credit6.4 Yes20272042
Utah research credit6.9 No20222036
California research credit4.0 NoIndefiniteIndefinite
Schedule of Unrecognized Tax Benefits The Company’s gross unrecognized tax benefits as of the year ended December 31, 2021, the transition period ended December 31, 2020 and the years ended June 30, 2020 and 2019, and the changes in those balances are as follows: 
Year Ended December 31,Six-month Transition Period Ended December 31,Years Ended June 30,
(in millions)2021202020202019
Unrecognized tax benefits at the beginning of period$37.6 $23.5 $21.7 $24.9 
Gross increases - current year tax positions1.4 13.9 1.6 2.2 
Gross increases - prior year tax positions1.1 1.0 0.7 0.5 
Gross increases - acquisitions— — — 2.3 
Gross decreases - prior year tax positions(2.8)(0.1)— (0.1)
Gross decreases - settlements(5.1)— — (2.7)
Gross decreases - statute lapse(0.1)(0.7)(0.5)(5.4)
Unrecognized tax benefits at end of year$32.1 $37.6 $23.5 $21.7 
Interest and penalties in year-end balance$3.3 $2.2 $1.4 $0.8